US Bancorp’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

US Bancorp’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-562	Closed	-$15K	–	4236
2021 Q2	$15K	Buy	562 +162	+41%	+$3.18K	﹤0.01%	3276
2021 Q1	$7K	Sell	400 -54	-12%	-$1.23K	﹤0.01%	3434
2020 Q4	$8K	Buy	+454	New	+$8.13K	﹤0.01%	3287
2020 Q3	–	Sell	-110	Closed	-$2K	–	3927
2020 Q2	$2K	Buy	+110	New	+$1.66K	﹤0.01%	3559

US Bancorp's TBIO Position: Q3 2021 in Review

US Bancorp sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 562 shares — an estimated $15K sold.

US Bancorp first reported a position in TBIO in Q2 2020 and held it in 4 quarters. The position peaked at $15K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

US Bancorp reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
US Bancorp sold 562 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $15K.
US Bancorp first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
US Bancorp's Translate Bio, Inc. Common Stock position peaked at $15K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on US Bancorp's 13F filing for Q3 2021, filed 10 Nov 2021.